Highlights Tianda Pharmaceuticals Limited

Equities

455 KYG887471038

Market Closed - Hong Kong S.E. Other stock markets 01:38:20 14/05/2024 pm IST			5-day change	1st Jan Change
0.246 ^HKD	+0.41%		-7.17%	+12.84%

26/03	Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/03	Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	26/03	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023	21/03	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%	24/23/24	MT
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023	23/23/23	CI
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical	02/23/02	MT
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.	01/23/01	CI
Tianda Pharmaceuticals Limited Approves Final Dividend	27/23/27	CI
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023	19/23/19	CI
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023	23/23/23	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23/23/23	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23/23/23	CI
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%	20/23/20	MT
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022	19/23/19	CI
Tianda Pharmaceuticals' Loss for Half Year Through September Narrows	28/22/28	MT
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended September 30, 2022	25/22/25	CI
Tianda Pharmaceuticals Chairman Buys 1.9 Million Shares; Stock Rises 3%	28/22/28	MT
Tianda Pharmaceuticals Limited Declares Final Dividend	31/22/31	CI
Tianda Pharmaceuticals Limited Declares Special Dividend	31/22/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Tianda Pharmaceuticals Limited

Equities

455

KYG887471038

Highlights

Filters